Search Results - "Harrer, Grant"

Phase II Evaluation of Early Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel Combined With Hormonal Therapy in Patients With High-risk Metastatic Prostate Adenocarcinoma: Southwest Oncology Group S0032 by Smith, David C, Tangen, Cathy M, Van Veldhuizen, Peter J, Harrer, Grant W, Golshayan, Ali, Mills, Glenn M, Vogelzang, Nicholas J, Thompson, Ian M, Hussain, Maha H.A

“…Objectives To assess the efficacy of a multiagent taxane-based chemotherapy combined with hormonal therapy in men with metastatic androgen-dependent prostate…”
Get full text

Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination with Hormone Therapy in Patients with High-Risk Metastatic Adenocarcinoma of the Prostate: Southwest Oncology Group (SWOG) S0032 by Smith, David C., Tangen, Cathy M., Hussain, Maha H.A., Van Veldhuizen, Peter J., Harrer, Grant W., Stuart, Robert K., Mills, Glenn M., Vogelzang, Nicholas J., Thompson, Ian M.

Get full text

Phase II Study of Gemcitabine and Bevacizumab As First-Line Treatment in Taxane-Pretreated, HER2-Negative, Locally Recurrent or Metastatic Breast Cancer by Borson, Rachel, Harker, Graydon, Reeves, James, Beck, Thaddeus, Hager, Steven, Horvath, William, Jones, Michael, Tillinghast, Guy, Arrowsmith, Edward, Harrer, Grant, Kudrik, Fred J, Malamud, Stephen C, Bromund, Jane, Zeigler, Haoyue, Tai, Datchen Fritz, Kornberg, Lori J, Obasaju, Coleman, Orlando, Mauro, Yardley, Denise A

“…Micro-Abstract This single-arm phase II trial involving women with recurrent or metastatic breast cancer examined the efficacy and safety of adding bevacizumab…”
Get full text